Radient Technologies Inc. Launches bioU, a Brand of High Quality Cannabis Extract Formulations Exclusively for Medical Cannabis by Shoppers

EDMONTON, Alberta, May 21, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce the launch of bioU, a scientifically formulated brand exclusively sold to Medical Cannabis by Shoppers™ (“Shoppers”), a subsidiary of Shoppers Drug Mart Inc.,Continue reading “Radient Technologies Inc. Launches bioU, a Brand of High Quality Cannabis Extract Formulations Exclusively for Medical Cannabis by Shoppers”

Emerald Announces $2.1 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 21, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed, subjectContinue reading “Emerald Announces $2.1 Million Prospectus Sale”

Khiron Begins Sales of First High-THC Medical Cannabis in Colombia

Khiron is the first company to receive authorization to commercialize high-THC medical cannabis magistral preparations from Colombia’s National Narcotics Fund Authorization is supplementary to the previously announced high-THC extraction and cultivation quotas from the Colombian Technical Quotas Group Effective immediately, prescriptions will be filled through Company’s ILANS clinics, with expanded distribution in Colombia as partner pharmacies receive dispensary permitsContinue reading “Khiron Begins Sales of First High-THC Medical Cannabis in Colombia”

VIVO Cannabis™ Announces First Quarter 2020 Results

Net revenue was $8.2 million, an increase of 24% over Q4 2019 Initiated spring planting in Napanee airhouses Additional production and extraction capacity expected to be operational in Q2 2020 NAPANEE, ON, May 14, 2020 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company“) today released its first quarter 2020 financial and operating results. Management Commentary “Our positive first quarterContinue reading “VIVO Cannabis™ Announces First Quarter 2020 Results”

MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos

BARRIE, Ontario, May 15, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”) has secured its first European white-label cannabisContinue reading “MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos”

FSD Pharma Reports First Quarter 2020 Financial Results

Provides Business Update TORONTO, May 14, 2020 /CNW/ – FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management’s discussion and analysis of financial condition and results of operations (“MD&A”) for the three months ended March 31, 2020 have been filed and can be viewed on the Company’s SEDAR profile at www.sedar.com. FSD also provided anContinue reading “FSD Pharma Reports First Quarter 2020 Financial Results”

The Valens Company Enters Australia’s Rapidly Expanding Cannabis Market with Five Year Distribution Agreement with Country’s Largest Distributor

Landmark agreement provides The Valens Company with strategic access to the second largest cannabis market outside of North America. Under the terms of the five-year agreement, The Valens Company becomes a preferred supplier to Cannvalate, a leading authority in the Australian medical cannabis community with the largest cannabis distribution platform in the country. Partnership provides theContinue reading “The Valens Company Enters Australia’s Rapidly Expanding Cannabis Market with Five Year Distribution Agreement with Country’s Largest Distributor”

Tetra Bio-Pharma Announces Overnight Marketed Offering

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES OTTAWA, May 14, 2020 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSXV:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce it has commenced an overnight marketed public offering (the “Offering”) of units (the “Units”) of theContinue reading “Tetra Bio-Pharma Announces Overnight Marketed Offering”

Columbia Care Reports First Quarter 2020 Results

First Quarter Combined Revenue up 125% YoY to $28.9 Million, Sequential Increase of 18% and Sequential Gross Margin Improvement of 7% Consumer Demand Through April Remains Strong Amid COVID-19 NEW YORK–(BUSINESS WIRE)–Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today reported financial and operating results for theContinue reading “Columbia Care Reports First Quarter 2020 Results”